Our hypothesis that loss of protein expression would be higher in advanced stages of BE was refuted, since we found loss of MLH1/PMS2 expression in all three groups, most commonly in EAC group but also in 50% of patients without dysplasia. This evidence concerns the gene PMS2 and Barrett esophagus.